Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.

@article{AhlstrmEmanuelsson2002EstablishingAM,
  title={Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.},
  author={Cecilia Ahlstr{\"o}m-Emanuelsson and Carl Persson and Christer Svensson and Morgan Andersson and Z Hossz{\'u} and Anders {\AA}kerlund and Lennart Greiff},
  journal={Annals of allergy, asthma \& immunology : official publication of the American College of Allergy, Asthma, \& Immunology},
  year={2002},
  volume={89 2},
  pages={
          159-65
        }
}
Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma
TLDR
Symptom scores and NBI were similar for the 2 groups, except for nasal obstruction and rhinorrhea, which were more marked in subjects with asthma and Rhinitis, respectively.
Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
  • M. Korsgren, M. Andersson, L. Greiff
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 2007
Symptoms and aspects on eosinophil activity in allergic rhinitis
TLDR
It is demonstrated that repeated individualized allergen challenges can produce symptoms and signs that mimic seasonal disease and that production of the eosinophil chemokine CCL5 is particularly corticosteroid sensitive, suggesting that it may be a valid treatment target.
Allergic Rhinitis in Children: Selecting an Intranasal Corticosteroid
TLDR
Four once-daily, aqueous formulations of intranasal corticosteroids are available in the United States for pediatric patients and results of comparative studies show that all four appear to be similar in efficacy and tolerability.
Effects of Clara cell 10 (CC10) protein on symptoms and signs of allergic rhinitis.
Experimental models for the evaluation of treatment of allergic rhinitis.
Once-Daily Administration of Intranasal Corticosteroids for Allergic Rhinitis: A Comparative Review of Efficacy, Safety, Patient Preference, and Cost
TLDR
BANS was associated with more days of treatment per prescription at a lower cost per day for adults compared with the other INSs and is the only INS with a pregnancy category B rating.
...
...

References

SHOWING 1-10 OF 11 REFERENCES
Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
Dual symptomatic and exudative nasal responses are not characteristics of perennial allergic rhinitis.
TLDR
It is concluded that nasal symptomatic and exudative late phase responses may not be a general feature, even in subjects with perennial rhinitis challenged with high, symptom-provoking, doses of HDM allergen.
Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.
  • E. Bronsky, D. Aaronson, K. Nolop
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 1997
Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
  • E. Meltzer
  • Medicine
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • 1998
Mediator release after nasal airway challenge with allergen.
TLDR
This system, for the first time, clearly relates an in vivo symptom and mediator release and thus should provide an excellent tool for the further study of the allergic response and nasal pathophysiology.
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
TLDR
The high safety margin of inhaled therapy with GCSs has encouraged an increasingly widespread use of these compounds in patients with moderate to severe asthma over the past 20 years, and especially where high firstpass metabolism to inactive compounds in the liver has been demonstrated.
Generation of clusters of free eosinophil granules (Cfegs) in seasonal allergic rhinitis
TLDR
It is concluded that generation of Cfegs is a significant feature of seasonal allergic rhinitis and that this process represents the ultimate activation of mucosal eosinophils in this disease.
Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.
TLDR
The nature and extent of the ECL and its product indicate that allergen-induced cytolysis is a primary and major mechanism for the release of eosinophil proteins in human allergic airway inflammation in vivo.
Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis
TLDR
The exudative response is similar in the nose and bronchi and exudation occurs in both allergic asthma and rhinitis, and the educational response is a specific end‐organ function of the mucosal microcirculation that may be altered in airway diseases.
...
...